Prostate Cancer - Results from #21700

Target volume coverage and dose to organs at risk in prostate cancer patients : Dose calculation on daily cone-beam CT data sets - Abstract February 12, 2014

Metformin in chemotherapy-naive castration-resistant prostate cancer: A multicenter phase 2 trial (SAKK 08/09) - Abstract February 12, 2014

Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases - Abstract February 12, 2014

Volumetric modulated arc therapy for prostate cancer patients with hip prosthesis - Abstract February 12, 2014

Comparison of dosimetric variation between prostate IMRT and VMAT due to patient's weight loss: Patient and phantom study - Abstract February 12, 2014

Long-term outcomes of prostate cancer patients treated with combined brachytherapy and maximal androgen blockade - Abstract February 12, 2014

Focal therapy and prostate cancer - Abstract February 11, 2014

Urinary continence in laparoscopic radical prostatectomy with bladder neck preservation - Abstract February 11, 2014

Helical intensity-modulated radiotherapy of the pelvic lymph nodes with integrated boost to the prostate bed - Initial results of the PLATIN 3 trial - Abstract February 11, 2014

Androgen deprivation therapy improves pneumoperitoneum time during laparoscopic radical prostatectomy in Japanese patients with enlarged prostates - Abstract February 11, 2014

Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy - Abstract February 11, 2014

OncoGenex announces target number of events reached in phase 3 SYNERGY trial of custirsen in metastatic castrate-resistant prostate cancer February 11, 2014

It ain't what you do, it's the way you do it: Five golden rules for transforming prostate-specific antigen screening - Abstract February 11, 2014

Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy? - Abstract February 11, 2014

A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality - Abstract February 11, 2014

Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer - Abstract February 10, 2014

Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents - Abstract February 10, 2014

Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer - Abstract February 10, 2014

On the sensitivity of α/β prediction to dose calculation methodology in prostate brachytherapy - Abstract February 10, 2014

The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period - Abstract February 10, 2014

Page 1086 of 1458